Detalhe da pesquisa
1.
Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.
J Virol
; 91(18)2017 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28701395
2.
CD25+ FoxP3+ Memory CD4 T Cells Are Frequent Targets of HIV Infection In Vivo.
J Virol
; 90(20): 8954-67, 2016 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27384654
3.
Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.
BMC Infect Dis
; 16: 344, 2016 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-27450538
4.
The impact of intragenic CpG content on gene expression.
Nucleic Acids Res
; 38(12): 3891-908, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20203083
5.
HPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East Africa.
Front Oncol
; 11: 763717, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34917506
6.
Envelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and Sequence.
Front Immunol
; 10: 717, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31105688
7.
Regulatory T cell abundance and activation status before and after priming with HIVIS-DNA and boosting with MVA-HIV/rgp140/GLA-AF may impact the magnitude of the vaccine-induced immune responses.
Immunobiology
; 223(12): 792-801, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30121146
8.
Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
PLoS One
; 13(11): e0206838, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30496299
9.
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.
PLoS One
; 11(5): e0155702, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27192151
10.
Maturation and Mip-1ß Production of Cytomegalovirus-Specific T Cell Responses in Tanzanian Children, Adolescents and Adults: Impact by HIV and Mycobacterium tuberculosis Co-Infections.
PLoS One
; 10(5): e0126716, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25974183
11.
Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.
PLoS One
; 10(4): e0119629, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25875843
12.
Helminth-associated systemic immune activation and HIV co-receptor expression: response to albendazole/praziquantel treatment.
PLoS Negl Trop Dis
; 8(3): e2755, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24675895
13.
Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study.
Lancet Infect Dis
; 14(10): 931-8, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25185458
14.
Regulatory T cell abundance and activation status before and after priming with HIVIS-DNA and boosting with MVA-HIV/rgp140/GLA-AF may impact the magnitude of the vaccine-induced immune responses
Immunobiol., Suppl
; 223(12): 792-801, dez 2018. fig, tab
Artigo
Inglês
| RSDM | ID: biblio-1523785
15.
Multiparameter RNA and codon optimization: a standardized tool to assess and enhance autologous mammalian gene expression.
PLoS One
; 6(3): e17596, 2011 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-21408612